Search Results 1191-1200 of 19039 for Neutrophil

  1. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1,500/uL; Platelet (PLT) = 100,000/uL; Activated partial thromboplastin time (APTT) < 1.2 times upper limit of normal (ULN); ...

  2. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

    Absolute neutrophil count ≥ 1.5 x 10^9 /L without colony stimulating factor support for at least 7 days prior to Screening;; Platelets ≥ 100 x 10^9 /L ...

  3. Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic - Mayo Clinic

    Absolute neutrophil count (ANC) >= 1,500/mcL; Platelets (PLT) >= 100,000/mcL; Aspartate aminotransferase (AST) =< 2.5 x upper limit of normal (ULN); if liver ...

  4. A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1.5 x 10^3 /µL;; Platelet count ≥100 x 10^3 /µL;; Hemoglobin ≥ 9 g/dL;; In subjects transfused before study entry ...

  5. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

    - Absolute neutrophil count (ANC) >= 0.75 x10^9/L (must be performed within 28 days prior to registration) - Note: growth factor and transfusion utilization ...

  6. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    Absolute neutrophil count >= 0.7 x 10^9/L unless marrow was involved by CLL or RT, then absolute neutrophil count (ANC) >= 0.3 x 10^9/L (=< 14 days prior to ...

  7. A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    absolute neutrophil count (ANC) ≥ 1000/mm^3;; platelets ≥ 50,000/mm^3;; hemoglobin ≥ 8.0 g/dL;; Transfusion and / or growth factor support is permitted ...

  8. Ixabepilone and Temsirolimus in Treating Patients with Solid Tumors that are Metastatic or Cannot ce Removed by Surgery - Mayo Clinic

    Absolute neutrophil count ≥ 1500/mcL; Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin < 1.5 mg/dL; Serum glutamate pyruvate transaminase ...

  9. Comparing Retreatment Of 177Lu-DOTATATE PRRT Versus Everolimus In Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial - Mayo Clinic

    - Absolute neutrophil count >= 1.0 x 10^9/L (>= 1000/mm^3) (measured within 28 days prior to enrollment) - Platelets >= 80 x 10^9/L (>= 80 x 10^3/mm^3 ...

  10. Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma - Mayo Clinic

    Absolute Neutrophil Count (ANC) ≥ 1.0 x 109/L; Platelets ≥ 100 x 109/L; Hemoglobin ≥ 9.0 g/dL; INR ≤ 2 x ULN; Potassium, calcium, magnesium ≤ Grade 1 per ...